These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11134507)

  • 21. Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis.
    Baldini L; Lenci E; Bianchini F; Trabocchi A
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.
    Maeshima Y; Yerramalla UL; Dhanabal M; Holthaus KA; Barbashov S; Kharbanda S; Reimer C; Manfredi M; Dickerson WM; Kalluri R
    J Biol Chem; 2001 Aug; 276(34):31959-68. PubMed ID: 11399763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
    Nisato RE; Tille JC; Jonczyk A; Goodman SL; Pepper MS
    Angiogenesis; 2003; 6(2):105-19. PubMed ID: 14739617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans.
    Vallon M; Essler M
    J Biol Chem; 2006 Nov; 281(45):34179-88. PubMed ID: 16982628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the expression of alpha(v)beta3 integrin receptors in non-malignant and malignant human cervical tumor tissues.
    Chattopadhyay N; Chatterjee A
    J Exp Clin Cancer Res; 2001 Jun; 20(2):269-75. PubMed ID: 11484986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrins as targets of angiogenesis inhibition.
    Westlin WF
    Cancer J; 2001; 7 Suppl 3():S139-43. PubMed ID: 11779085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
    Kim YM; Jang JW; Lee OH; Yeon J; Choi EY; Kim KW; Lee ST; Kwon YG
    Cancer Res; 2000 Oct; 60(19):5410-3. PubMed ID: 11034081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo.
    Martínez-Poveda B; Muñoz-Chápuli R; Rodríguez-Nieto S; Quintela JM; Fernández A; Medina MA; Quesada AR
    Mol Cancer Ther; 2007 Oct; 6(10):2675-85. PubMed ID: 17938261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific alpha v integrin receptors modulate K1735 murine melanoma cell behavior.
    Yang Y; Dang D; Atakilit A; Schmidt B; Regezi J; Li X; Eisele D; Ellis D; Ramos DM
    Biochem Biophys Res Commun; 2003 Sep; 308(4):814-9. PubMed ID: 12927791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
    Erdreich-Epstein A; Shimada H; Groshen S; Liu M; Metelitsa LS; Kim KS; Stins MF; Seeger RC; Durden DL
    Cancer Res; 2000 Feb; 60(3):712-21. PubMed ID: 10676658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.
    Vacca A; Ria R; Presta M; Ribatti D; Iurlaro M; Merchionne F; Tanghetti E; Dammacco F
    Exp Hematol; 2001 Aug; 29(8):993-1003. PubMed ID: 11495705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation.
    Pasco S; Monboisse JC; Kieffer N
    J Biol Chem; 2000 Oct; 275(42):32999-3007. PubMed ID: 10934203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
    Liu N; Lapcevich RK; Underhill CB; Han Z; Gao F; Swartz G; Plum SM; Zhang L; Green SJ
    Cancer Res; 2001 Feb; 61(3):1022-8. PubMed ID: 11221828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells.
    Maubant S; Saint-Dizier D; Boutillon M; Perron-Sierra F; Casara PJ; Hickman JA; Tucker GC; Van Obberghen-Schilling E
    Blood; 2006 Nov; 108(9):3035-44. PubMed ID: 16835373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis.
    Minamiguchi K; Kumagai H; Masuda T; Kawada M; Ishizuka M; Takeuchi T
    Int J Cancer; 2001 Aug; 93(3):307-16. PubMed ID: 11433393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiophene-based vitronectin receptor antagonists.
    Bubenik M; Meerovitch K; Bergeron F; Attardo G; Chan L
    Bioorg Med Chem Lett; 2003 Feb; 13(3):503-6. PubMed ID: 12565960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin.
    Koh JT; Kook H; Kee HJ; Seo YW; Jeong BC; Lee JH; Kim MY; Yoon KC; Jung S; Kim KK
    Exp Cell Res; 2004 Mar; 294(1):172-84. PubMed ID: 14980512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions.
    Pilch J; Habermann R; Felding-Habermann B
    J Biol Chem; 2002 Jun; 277(24):21930-8. PubMed ID: 11934894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.